Despite a long-standing no-comment policy, Humana made a one-time exception in its filing “in light of the significant investor speculation and persistent market rumors regarding [its] intentions with respect to pursuing a combination with Centene Corp.” Humana said it “will not make a proposal to combine with Centene as an alternative to Centene’s proposed transaction with WellCare Health Plans.”
The filing sent Centene’s stocks tumbling 8.3 percent in morning trading June 3. Humana’s stock was up 5.5 percent, according to Barron’s.
The rumors arose as Centene faced pressure from activist hedge funds to seek a possible sale rather than acquiring WellCare in a proposed $17.3 billion deal.
More articles on payer:
Centene got better deal on WellCare as market slid
Cigna CEO’s threat to leave Connecticut derailed public option, state official says
Allina | Aetna enrollment tops 12,000
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.